MitraClip Procedure Can Be Performed without General Anesthesia

Courtesy of Dr. Carlos Fava.

Avoiding general anesthesia in intervention procedures has the benefits of faster recovery and shorter hospitalization. This has been already analyzed in the context of TAVR, but not in MitraClip procedures.

Es posible realizar MitraClip sin anestesia general

The present study analyzed 232 patients receiving the MitraClip. 76 of these procedures were done under general anesthesia (32.7%) and 156 under deep sedation (67.3%).


Read also: The SOURCE 3 Confirms the Good Outcomes of the SAPIEN 3 at One Year Followup”.


Populations were similar in age, comorbidities, EuroScore, severity of mitral failure, left and right ventricular function, and renal function.

 

Both strategies saw safe MitraClip implantation, with no difference in number of implanted clips, or residual mitral failure (with low complications rate). Only 2 patients required conversion to general anesthesia. Total procedural time was lower with deep sedation (DS), driven mainly by preparation.

 

Intensive care was shorter with DS (2.6±4.4 vs. 1.5±1.4 p=0.003). However, hospital stay was similar.


Read also: New Study Confirms TAVR Durability at 5 Years”.


At 90 day follow up, both groups improved functional class and quality of life, saw reduced systolic pressure and BNP.

 

Conclusion

MitraClip implantation with DS is as safe and effective as with general anesthesia.

 

Commentary

Simplifying endovascular procedures with no quality compromise has always been beneficial.

 

Performing MitraClip procedures without general anesthesia reduced intensive care days, but with no difference in overall hospital stay. This might be because the researchers looked at patients between 2011 and 2015. After gaining experience and improving devices, this factor might improve as well. 

 

To know the kind of patients that will benefit from this strategy calls for further research.

 

Courtesy of Dr. Carlos Fava.

 

Original Title: Deep Sedation Vs. Geneal Anesthesia in 232 patients undergoing Percutaneous Mitral Valve repair using the MitraClip® System.

Reference: Patrick Horn, et al Catheterization Cardiovascular Intervention 2017 Published online.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...